Fiche maladie | 2024.03.12
Mpox is a virus that was initially present in animals, especially rodents in Africa, and now circulates among humans – it is referred to as an emerging zoonotic disease. The disease caused by this virus is also known as mpox (formerly monkeypox), and presents as a mild form of smallpox, with less severe symptoms and a lower case-fatality rate (the number of deaths as a proportion of the number of...
Document de presse | 2005.01.10
In response to the risk of epidemics in the regions affected by the disaster, the Institut Pasteur, which is engaged in the battle against infectious diseases on a daily basis, has mobilized. The expert in charge of the Institut Pasteur Emergency Cell for Biological intervention (CIBU) is currently on a mission in Sri Lanka to participate in evaluating the risk of epidemics in this region. At the...
Document de presse | 2017.09.25
Scientists from the Institut Pasteur in Paris and the Institut Pasteur in Cambodia, in collaboration with teams from the CNRS and Inria, have demonstrated that asymptomatic dengue infection in children is associated with activation of the immune system via control mechanisms, resulting in the elimination of viral infection without excessive immune activation. This paper, published in the...
News | 2020.11.24
«Pasteur Network Talent Awards» 2020 were presented on Thursday 19 November 2020 to Dr Sophie Valkenburg and Dr Roman Thibeaux by Pr Pierre-Marie Girard, Institut Pasteur vice-president international Affairs and by Prof. Stewart Cole, President of The Institut Pasteur.Due to the COVID-19 pandemic, these awards were presented by videoconference during the 52nd Council of Directors of the...
News | 2021.05.31
Diphtheria is a severe infection caused in humans by toxigenic strains of Corynebacterium diphtheriae bacteria. If left untreated, it leads to death in 5 to 25% of cases. It generally affects the upper respiratory tracts, causing pseudomembrane formation and sometimes leading to suffocation. The infection can be complicated by systemic symptoms caused by the diphtheria toxin. Scientists from the...
Article | 2020.08.13
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...
Article | 2017.08.08
VACCINATIONSBefore traveling abroad, a vaccination schedule should be drawn up based on two criteria:Administrative obligation: the measures adopted by the country to protect against an infectious risk from another country, rather than the actual risks for the traveler.The actual risks for the traveler: these vary depending on the health situation of the country they are going to, the...
Document de presse | 2004.03.17
With a third of the world's population infected, 2 million deaths and 8.5 million new cases each year, tuberculosis (TB) is the number two infectious disease in the world after AIDS, without sparing France, where 6300 new cases occurred last year. The prevalence of the resistance to antibiotics and the emergence of multiresistance are worrying at the international level, and is a risk for...
Document de presse | 2012.04.18
Researchers from the Institut Pasteur and Inserm, in collaboration with researchers from the University of Pisa, have uncovered the key role played by specific proteins in the virulence of the mycobacterium responsible for tuberculosis, Mycobacterium tuberculosis. They were able to create an attenuated strain of the mycobacterium, which confers a better protection against tuberculosis than the...
News | 2023.12.19
Flaviviruses are pathogens transmitted by ticks that can cause serious diseases including neurological disorders. A study conducted at the Institut Pasteur reveals how these viruses can slip between the cracks of immunity.